References analysis of the Wikipedia article "Paraxanthine" in the English version

doi.org

Stavric, B. (1988-01-01). "Methylxanthines: Toxicity to humans. 3. Theobromine, paraxanthine and the combined effects of methylxanthines". Food and Chemical Toxicology. 26 (8): 725–733. doi:10.1016/0278-6915(88)90073-7. ISSN 0278-6915. PMID 3058562.

Mazzafera P (May 2004). "Catabolism of caffeine in plants and microorganisms". Frontiers in Bioscience. 9 (1–3): 1348–59. doi:10.2741/1339. PMID 14977550.

Fuhr U, Doehmer J, Battula N, Wölfel C, Flick I, Kudla C, Keita Y, Staib AH (October 1993). "Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolones". Toxicology. 82 (1–3): 169–89. doi:10.1016/0300-483x(93)90064-y. PMID 8236273.

Guerreiro S, Toulorge D, Hirsch E, Marien M, Sokoloff P, Michel PP (October 2008). "Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels". Molecular Pharmacology. 74 (4): 980–9. doi:10.1124/mol.108.048207. PMID 18621927. S2CID 14842240.

Graham TE, Rush JW, van Soeren MH (June 1994). "Caffeine and exercise: metabolism and performance". Canadian Journal of Applied Physiology. 19 (2): 111–38. doi:10.1139/h94-010. PMID 8081318.

Mazzafera P (May 2004). "Catabolism of caffeine in plants and microorganisms". Frontiers in Bioscience. 9 (1–3): 1348–59. doi:10.2741/1339. PMID 14977550.

Summers RM, Mohanty SK, Gopishetty S, Subramanian M (May 2015). "Genetic characterization of caffeine degradation by bacteria and its potential applications". Microbial Biotechnology. 8 (3): 369–78. doi:10.1111/1751-7915.12262. PMC 4408171. PMID 25678373.

Müller, Christa E.; Jacobson, Kenneth A. (2011), Fredholm, Bertil B. (ed.), "Xanthines as Adenosine Receptor Antagonists", Methylxanthines, Handbook of Experimental Pharmacology, vol. 200, no. 200, Springer, pp. 151–199, doi:10.1007/978-3-642-13443-2_6, ISBN 978-3-642-13443-2, PMC 3882893, PMID 20859796

Orrú, Marco; Guitart, Xavier; Karcz-Kubicha, Marzena; Solinas, Marcello; Justinova, Zuzana; Barodia, Sandeep Kumar; Zanoveli, Janaina; Cortes, Antoni; Lluis, Carme; Casado, Vicent; Moeller, F. Gerard (April 2013). "Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans". Neuropharmacology. 67C: 476–484. doi:10.1016/j.neuropharm.2012.11.029. ISSN 0028-3908. PMC 3562388. PMID 23261866.

Ferré, Sergi; Orrú, Marco; Guitart, Xavier (2013). "Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission". Journal of Caffeine Research. 3 (2): 72–78. doi:10.1089/jcr.2013.0006. ISSN 2156-5783. PMC 3680978. PMID 24761277.

Orrú, Marco (2013). "Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans". Neuropharmacology. 67C: 476–484. doi:10.1016/j.neuropharm.2012.11.029. PMC 3562388. PMID 23261866.

Essayan DM (November 2001). "Cyclic nucleotide phosphodiesterases". The Journal of Allergy and Clinical Immunology. 108 (5): 671–80. doi:10.1067/mai.2001.119555. PMID 11692087.

Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R (June 2008). "Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition". Clinics. 63 (3): 321–8. doi:10.1590/S1807-59322008000300006. PMC 2664230. PMID 18568240.

Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U (February 1999). "Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages". American Journal of Respiratory and Critical Care Medicine. 159 (2): 508–11. doi:10.1164/ajrccm.159.2.9804085. PMID 9927365.

Peters-Golden M, Canetti C, Mancuso P, Coffey MJ (January 2005). "Leukotrienes: underappreciated mediators of innate immune responses". Journal of Immunology. 174 (2): 589–94. doi:10.4049/jimmunol.174.2.589. PMID 15634873.

Hawke TJ, Willmets RG, Lindinger MI (November 1999). "K+ transport in resting rat hind-limb skeletal muscle in response to paraxanthine, a caffeine metabolite". Canadian Journal of Physiology and Pharmacology. 77 (11): 835–43. doi:10.1139/y99-095. PMID 10593655.

Hawke TJ, Allen DG, Lindinger MI (December 2000). "Paraxanthine, a caffeine metabolite, dose dependently increases [Ca(2+)](i) in skeletal muscle". Journal of Applied Physiology. 89 (6): 2312–7. doi:10.1152/jappl.2000.89.6.2312. PMID 11090584. S2CID 11369121.

Lelo, A.; Birkett, D. J.; Robson, R. A.; Miners, J. O. (August 1986). "Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man". British Journal of Clinical Pharmacology. 22 (2): 177–182. doi:10.1111/j.1365-2125.1986.tb05246.x. ISSN 0306-5251. PMC 1401099. PMID 3756065.

Neal L. Benowitz; Peyton Jacob; Haim Mayan; Charles Denaro (1995). "Sympathomimetic effects of paraxanthine and caffeine in humans". Clinical Pharmacology & Therapeutics. 58 (6): 684–691. doi:10.1016/0009-9236(95)90025-X. PMID 8529334. S2CID 22747642.

York, R. G.; Randall, J. L.; Scott, W. J. (1986). "Teratogenicity of paraxanthine (1,7-dimethylxanthine) in C57BL/6J mice". Teratology. 34 (3): 279–282. doi:10.1002/tera.1420340307. ISSN 0040-3709. PMID 3798364.

Gressner, Olav A.; Lahme, Birgit; Siluschek, Monika; Gressner, Axel M. (2009). "Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells". Liver International. 29 (6): 886–897. doi:10.1111/j.1478-3231.2009.01987.x. ISSN 1478-3231. PMID 19291178. S2CID 32926935.

Nakatsuka, Toshio; Hanada, Satoshi; Fujii, Takaaki (1983). "Potentiating effects of methylxanthines on teratogenicity of mitomycin C in mice". Teratology. 28 (2): 243–247. doi:10.1002/tera.1420280214. ISSN 1096-9926. PMID 6417813.

Weinstein, David; Mauer, Irving; Katz, Marion L.; Kazmer, Sonja (1975). "The effect of methylxanthines on chromosomes of human lymphocytes in culture". Mutation Research/Environmental Mutagenesis and Related Subjects. 31 (1): 57–61. doi:10.1016/0165-1161(75)90064-3. ISSN 0165-1161. PMID 1128545.

nih.gov

pubmed.ncbi.nlm.nih.gov

Mazzafera P (May 2004). "Catabolism of caffeine in plants and microorganisms". Frontiers in Bioscience. 9 (1–3): 1348–59. doi:10.2741/1339. PMID 14977550.

Graham TE, Rush JW, van Soeren MH (June 1994). "Caffeine and exercise: metabolism and performance". Canadian Journal of Applied Physiology. 19 (2): 111–38. doi:10.1139/h94-010. PMID 8081318.

Mazzafera P (May 2004). "Catabolism of caffeine in plants and microorganisms". Frontiers in Bioscience. 9 (1–3): 1348–59. doi:10.2741/1339. PMID 14977550.

Daly JW, Jacobson KA, Ukena D (1987). "Adenosine receptors: development of selective agonists and antagonists". Progress in Clinical and Biological Research. 230 (1): 41–63. PMID 3588607.

Essayan DM (November 2001). "Cyclic nucleotide phosphodiesterases". The Journal of Allergy and Clinical Immunology. 108 (5): 671–80. doi:10.1067/mai.2001.119555. PMID 11692087.

Institute of Medicine (US) Committee on Military Nutrition Research (2001). Caffeine for the Sustainment of Mental Task Performance: Formulations for Military Operations. Washington (DC): National Academies Press (US). ISBN 978-0-309-08258-7. PMID 25057583.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

worldcat.org

Caffeine : chemistry, analysis, function and effects. Preedy, Victor R.,, Royal Society of Chemistry (Great Britain). Cambridge, U.K. 2012. ISBN 9781849734752. OCLC 810337257.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)

Paraxanthine (English Wikipedia)

books.google.com

caymanchem.com

doi.org

jimmunol.org

nature.com

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

worldcat.org